Zhejiang Shapuaisi Pharmaceutical Co. Ltd.SSE: 603168

Announcement on Shareholding Reduction Plan for Shareholders

Sep 27, 2025 · Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Sep 27, 2025

On 6ix: 6ix.com/news/announcement-on-shareholding-reduction-plan-for-shareholders-105

Announcement on Shareholding Reduction Plan for Shareholders

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix

Earlier from Zhejiang Shapuaisi Pharmaceutical

Announcement on Postponement of Investment Projects Financed by Raised FundsSep 25, 2025
Announcement on Resignation of Director and Election of Employee Representative DirectorSep 23, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Sep 17, 2025
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2025Sep 10, 2025
Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Drug Clinical Trials for Pilocarpine HCI Ophthalmic SolutionSep 4, 2025

Later from Zhejiang Shapuaisi Pharmaceutical

Announcement on the Implementation of Repurchase and Cancellation of Some Restricted Stocks in the 2023 Stock Option and Restricted Stock Incentive PlanOct 16, 2025
Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase Ⅲ Clinical Trial of Litasert Eye DropsOct 25, 2025
Announcement on Obtaining Notice of Approval for Drug Supplementary ApplicationOct 31, 2025
Announcement on Circulation of Restricted Shares Issued to Specific ObjectsNov 4, 2025
Announcement on Convening the Q3 2025 Performance BriefingNov 11, 2025

All Zhejiang Shapuaisi Pharmaceutical news releases

Follow Zhejiang Shapuaisi Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang Shapuaisi Pharmaceutical